









Mercados
/
Ações
/
nasdaq-mdt
/

Medtronic PLC

MDT

90.970USD

-0.760-0.83%

Fechamento 10/30, 16:00（ET）Cotações atrasadas em 15 min

116.61BValor de mercado

25.02P/L TTM



Medtronic PLC

90.970

-0.760-0.83%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Medtronic PLC Empresa

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Informações de Medtronic PLC



Código da empresaMDT

Nome da EmpresaMedtronic PLC

Data de listagemNov 21, 1977

CEOMr. Geoffrey S. (Geoff) Martha

Número de funcionários95000

Tipo de títulosOrdinary Share

Fim do ano fiscalNov 21

EndereçoBuilding Two Parkmore Business Park West

CidadeDUBLIN

Bolsa de valoresNYSE Consolidated

PaísIreland

Código postalH91 4K49

Telefone1135314381700

Sitehttps://www.medtronic.com/

Código da empresaMDT

Data de listagemNov 21, 1977

CEOMr. Geoffrey S. (Geoff) Martha

Executivos da empresa Medtronic PLC



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.90M

+78.68%

Mr. Brett A. Wall

Executive Vice President, President - Neuroscience Portfolio

548.61K

+10.51%

Mr. Gregory L. Smith

Executive Vice President - Enterprise Operations

186.13K

+56.07%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Americas

49.63K

+1.73%

Mr. Kendall J. (Ken) Powell

Independent Director

48.84K

+1.86%

Mr. Craig Arnold

Lead Independent Director

40.24K

+0.18%

Mr. Scott C. Donnelly

Independent Director

21.71K

+0.89%

Dr. Elizabeth G. (Betsy) Nabel, M.D.

Independent Director

17.64K

+0.41%

Mr. Kevin E. Lofton

Independent Director

8.19K

+0.89%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.90M

+78.68%

Mr. Brett A. Wall

Executive Vice President, President - Neuroscience Portfolio

548.61K

+10.51%

Mr. Gregory L. Smith

Executive Vice President - Enterprise Operations

186.13K

+56.07%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Americas

49.63K

+1.73%

Mr. Kendall J. (Ken) Powell

Independent Director

48.84K

+1.86%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Cardiac Rhythm & Heart Failure

1.71B

19.96%

Surgical & Endoscopy

1.61B

18.79%

Cranial & Spinal Technologies

1.21B

14.12%

Coronary & Peripheral Vascular

930.00M

10.84%

Specialty Therapies

702.00M

8.18%

Outro

2.41B

28.11%

Por RegiãoUSD

Nome

Receita

Proporção

Rest of World

4.32B

50.37%

United States

4.22B

49.24%

Ireland

33.00M

0.38%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Cardiac Rhythm & Heart Failure

1.71B

19.96%

Surgical & Endoscopy

1.61B

18.79%

Cranial & Spinal Technologies

1.21B

14.12%

Coronary & Peripheral Vascular

930.00M

10.84%

Specialty Therapies

702.00M

8.18%

Outro

2.41B

28.11%

Distribuição de ações

Atualizado em: sex, 15 de ago

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

9.85%

BlackRock Institutional Trust Company, N.A.

5.29%

State Street Investment Management (US)

4.67%

Capital Research Global Investors

2.83%

Geode Capital Management, L.L.C.

2.20%

Outro

75.16%

Investidores

Proporção

The Vanguard Group, Inc.

9.85%

BlackRock Institutional Trust Company, N.A.

5.29%

State Street Investment Management (US)

4.67%

Capital Research Global Investors

2.83%

Geode Capital Management, L.L.C.

2.20%

Outro

75.16%

Tipos de investidores

Investidores

Proporção

Investment Advisor

44.97%

Investment Advisor/Hedge Fund

29.17%

Research Firm

4.57%

Pension Fund

2.28%

Hedge Fund

2.25%

Bank and Trust

2.05%

Sovereign Wealth Fund

1.37%

Insurance Company

0.37%

Individual Investor

0.29%

Outro

12.70%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

3658

1.12B

87.15%

-15.13M

2025Q2

3762

1.12B

87.12%

-18.03M

2025Q1

3818

1.13B

88.15%

+2.18M

2024Q4

3768

1.12B

87.17%

+3.13M

2024Q3

3708

1.10B

85.63%

-24.55M

2024Q2

3725

1.11B

86.25%

-54.16M

2024Q1

3789

1.14B

85.95%

-7.87M

2023Q4

3780

1.13B

85.36%

-20.57M

2023Q3

3761

1.14B

85.37%

-14.93M

2023Q2

3764

1.13B

85.01%

-24.32M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

126.32M

9.85%

+1.88M

+1.51%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

67.84M

5.29%

-1.09M

-1.58%

Jun 30, 2025

State Street Investment Management (US)

59.83M

4.66%

-210.22K

-0.35%

Jun 30, 2025

Capital Research Global Investors

36.36M

2.83%

-5.21M

-12.53%

Jun 30, 2025

Geode Capital Management, L.L.C.

28.23M

2.2%

+310.68K

+1.11%

Jun 30, 2025

JP Morgan Asset Management

26.31M

2.05%

-1.69M

-6.03%

Jun 30, 2025

MFS Investment Management

19.36M

1.51%

-1.24M

-6.04%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

16.44M

1.28%

+1.87M

+12.83%

Jun 30, 2025

BlackRock Financial Management, Inc.

15.63M

1.22%

+1.48M

+10.48%

Jun 30, 2025

Goldman Sachs & Company, Inc.

14.73M

1.15%

+11.21M

+319.35%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: seg, 6 de out

Nome

Proporção

iShares U.S. Medical Devices ETF

4.68%

Cullen Enhanced Equity Income ETF

3.96%

USCF Dividend Income Fund

3.7%

iShares Health Innovation Active ETF

3.53%

First Trust Active Global Quality Income ETF

3.2%

Tema Heart & Health ETF

3.03%

Global X Aging Population ETF

2.95%

Morgan Dempsey Large Cap Value ETF

2.87%

Madison Covered Call ETF

2.8%

Madison Dividend Value ETF

2.56%

Ver Mais

iShares U.S. Medical Devices ETF

Proporção4.68%

Cullen Enhanced Equity Income ETF

Proporção3.96%

USCF Dividend Income Fund

Proporção3.7%

iShares Health Innovation Active ETF

Proporção3.53%

First Trust Active Global Quality Income ETF

Proporção3.2%

Tema Heart & Health ETF

Proporção3.03%

Global X Aging Population ETF

Proporção2.95%

Morgan Dempsey Large Cap Value ETF

Proporção2.87%

Madison Covered Call ETF

Proporção2.8%

Madison Dividend Value ETF

Proporção2.56%

Dividendo



Um total de 17.37B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Mar 06, 2025

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option

Mar 28, 2025

Apr 11, 2025

Mar 28, 2025

Dec 05, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option

Dec 27, 2024

Jan 10, 2025

Dec 27, 2024

Aug 16, 2024

MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option

Sep 27, 2024

Oct 11, 2024

Sep 27, 2024

May 23, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option

Jun 28, 2024

Jul 12, 2024

Jun 28, 2024

Mar 07, 2024

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option

Mar 22, 2024

Apr 12, 2024

Mar 21, 2024

Dec 07, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023

Dec 20, 2023

Jan 12, 2024

Dec 19, 2023

Aug 17, 2023

MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option

Sep 22, 2023

Oct 13, 2023

Sep 21, 2023

May 25, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option

Jun 23, 2023

Jul 14, 2023

Jun 22, 2023

Mar 02, 2023

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023

Mar 24, 2023

Apr 14, 2023

Mar 23, 2023

Dec 08, 2022

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022

Dec 21, 2022

Jan 13, 2023

Dec 20, 2022

Ver Mais

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

